Last Posted: Dec 04, 2019
- Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer prevention.
Griffin Natalie E et al. Gynecologic oncology 2019 Nov - Hypertrophic cardiomyopathy: genetics and clinical perspectives.
Wolf Cordula Maria et al. Cardiovascular diagnosis and therapy 2019 Oct 9(Suppl 2) S388-S415 - Cascade screening for familial hypercholesterolemia-identification of the C308Y mutation in multiple family members and relatives for the first time in mainland China.
Jin Weirong et al. BMC medical genetics 2019 Nov 20(1) 173 - Results and Lessons of a Pilot Study of Cascade Screening for Familial Hypercholesterolemia in US Primary Care Practices.
Neuner Joan et al. Journal of general internal medicine 2019 Oct - Genetic Counseling and Public Health in the Era of Precision Medicine
MJ Khoury, CDC Blog, September 18, 2019 - Familial Hypercholesterolemia Patients at High Risk for Cardiovascular Events Despite Treatment
PRNews, FH Foundation. Sepetmber 17, 2019 - Family health history: underused for actionable risk assessment.
Ginsburg Geoffrey S et al. Lancet (London, England) 2019 Aug - Making The Case For Cascade Screening Amongst Families With Inherited Heart Diseases.
Ingles Jodie et al. Heart rhythm 2019 Jul - Clinical Implications of Identifying Pathogenic Variants in Individuals With Thoracic Aortic Dissection.
Wolford Brooke N et al. Circulation. Genomic and precision medicine 2019 Jun 12(6) e002476 - Genetic Testing and Cascade Screening in Pediatric Long QT Syndrome and Hypertrophic Cardiomyopathy.
Knight Linda M et al. Heart rhythm 2019 Jun
.png)
No hay comentarios:
Publicar un comentario